Quibim

🚨 𝗧𝗵𝗲 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲: Patients with B-cell #lymphoma who relapse after two lines of treatment can be treated with chimeric antigen receptor T-cell therapy (CAR-T); however, a significant number of patients continue to progress or relapse after treatment.⁣ ⁣ 💡 𝗧𝗵𝗲 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻: Using QP-Insights in this multicenter retrospective study, we developed advanced image-based prognostic and #predictivemodels using logistic regression and Cox proportional hazards models to predict response to CAR-T therapy at 3 and 6 months, overall survival (OS), progression-free survival (PFS) and the occurrence of neurotoxicity (ICANS).⁣  ⁣ ✅ 𝗧𝗵𝗲 𝗿𝗲𝘀𝘂𝗹𝘁𝘀: The models combining clinical and imaging features significantly improved prediction accuracy compared to using clinical or imaging features alone and offer a promising tool for risk stratification and personalized treatment, potentially improving patient outcomes. ⁣  ⁣ 👉 Read our latest case study "Enhanced predictive models for B-Cell lymphoma patients undergoing CAR-T therapy" on our website: https://bit.ly/3W4sCtV #HealthInnovation #MedicalImaging

Diversity is our greatest strength: 🌟 Our international spirit drives innovation and collaboration across borders, cultivating a dynamic work environment where cultural diversity thrives. From Spain to France, Portugal to Canada, the Netherlands to the UK, and beyond, our team represents a rich mixture of perspectives and expertise 🌐 Embracing the mantra of "work from anywhere", flexibility and teamwork are our keys to delivering innovative healthcare solutions worldwide. We are more than proud to be #quibimers. #WFA #WFH #Team #Diversity

💻 Have you ever noticed a degradation in the performance of your #AI models? This can be a frequently asked question, and our latest blog focuses on one of AI's greatest challenges: model drift. Model drift refers to the decline in predictive power over time due to changes in #data.   In this article, Jose Munuera discusses supervised and unsupervised methods to detect drift, from statistical tests to uncertainty-based approaches, or analyzes essential steps to mitigate drift, such as model retraining and performance tuning. Read everything about it here 👉 https://bit.ly/4cXZR9m   #ArtificialIntelligence #HealthInnovation

🗣️ "With the integration of this technology into our diagnostic process, we are taking a significant step forward in addressing #prostatecancer, which is the most prevalent and the third highest in mortality rates among the male population. The use of artificial intelligence tools in radiology is already a reality, and in the context of prostate cancer, it is enabling us to optimize our workflows", Dr. Javier Blázquez Sánchez from Servicio de Radiología Hospital Universitario Ramón y Cajal. Hospital Ramón y Cajal has recently incorporated Quibim’s QP-Prostate technology into their diagnostic protocols for prostate cancer, achieving improved diagnostic accuracy and more efficient operations, ultimately leading to better clinical outcomes and #patientcare. #Radiology #AIinHealthcare #MedicalInnovation https://lnkd.in/d2KTvJue

Here's a sneak preview of some of our Q2 highlights: 1. Global expansion: We have closed the last quarter doubling the number of analyses 🌍 2. Advances in prostate cancer: Hospital de La Ribera and Hospital Universitario Nuestra Señora del Rosario are leveraging our AI-powered QP-Prostate software, improving early detection and treatment of #ProstateCancer 💪🏼 3. Stroke imaging breakthrough: the ROSSETTI project, led by Hospital Clínic de Barcelona, has reached a milestone with 4,600 patients enrolled and 3,700 imaging studies performed, using our QP-Insights platform for advanced stroke management 📊 4. Great Place to Work: Quibim has been named Best Place to Work in Technology 2024 by Great Place To Work Spain, with a 95% confidence level among our team 🏆 Want to read more details and receive the latest news? Subscribe to our newsletter and be the first to know: https://lnkd.in/dj9ybMpf #AIInHealthcare #GPTW #CancerCare #MedicalImaging

📊 With 4,600 patients, conducting 3,700 imaging studies and involving 16 medical centers across Spain, the Rossetti Project is dedicated to establishing a biobank that collects patient data about #stroke (ictus).   Led by Hospital Clínic de Barcelona and using the QP-Insights cloud platform to connect imaging data and enable advanced evaluations, this significant initiative facilitates the comprehensive collection of patient #data and aims to guide medical professionals in selecting the most effective treatment strategies for stroke management.   Dr. Jordi Blasco, Coordinator of Interventional Neuroradiology, praised the rapid growth and collaborative effort, highlighting the project's potential to inspire similar initiatives in other #healthcare areas. Read it here ➡ https://bit.ly/3WdSXaj

🌐 We are closing another quarter achieving major milestones: impacting twice as many patients and doubling the number of analyses! Partner by partner we continue to advance #PrecisionMedicine globally.

In this brief clip, our CMO, Glen Weiss, MD, MBA, provides a concise overview of the critical aspects of theranostic #Cancer immunotherapy in our webinar: "Cancer Immunotherapy Scanning Imaging as a Catalyst to Predict the Immune Response" 🎥 Did you miss it? Watch the entire session to explore the transformative role of predictive imaging biomarkers in immunotherapy responses and learn how integrating radiomics and #AI is pioneering sophisticated assessments in #Immunotherapy treatments.   Click here to watch it directly on our channel ➡️ https://lnkd.in/dibR6ik6 And here to watch the full webinar! ⬇

Bridging the gap between the public and private spheres of the medical system must be a pressing issue on the UK Health policy priorities, and having the advice of experts in the field is a great advantage. In this interview with MadTech, our CEO and Co-Founder, Ángel Alberich-Bayarri, highlights the importance of fostering through #AI an empowering environment for R&D and innovation, a crucial decision for the long-term improvement of the NHS and for maintaining the UK's competitive advantage in technology. 🗞 Read the full article here https://bit.ly/3RRyaqn

📢 Our CEO and Co-Founder Ángel Alberich-Bayarri continues to spread the word about the power of #AI in the medical field and initiatives like Fundación IMAGING. Today he participated in the roundtable "Practical applications of AI in companies", an event organized in our hometown, Valencia, by Fundación LAB Mediterráneo and Marina de Empresas. Moderated by Jorge Reverte Sevillano from NUNSYS Group, on this occasion, he shared the stage with representatives from AQUASERVICE.PT and PLD Space, highlighting how #ArtificialIntelligence is transforming many industries. Let's continue to lead the way towards a better and more efficient future!